cost of glp 1 drugs High Price GLP-1 Agents Tip Cost-Benefit Scale Unfavorably Are GLP-1 drugs worth their
Description
J Clin Endocrinol Metab (2017) 102(11):413647
Source: Polaris Market Research Analysis Key Players & Competitive Analysis Report The GLP-1 sector is witnesses competition due to revenue growth opportunities in both developed and emerging markets
In the following review article, we aim at reviewing the evidence related to the impact of GLP-1 RAs, on gastrointestinal procedures, mainly EGDs and colonoscopies, and their implications on the peri-operative period
This is another major differentiator from insulin
